18% of companies use China as a primary sourcing destination for manufacturing their products.
Today’s pharmaceutical manufacturers are faced with ever-growing pressures to evolve and transform their business strategies. Increasing cost pressures, tightened regulatory guidelines, and new technologies are forcing the industry to shape towards a more efficient and flexible operational model. As China becomes the second pharmaceutical market globally, reaching international quality standards is paramount in succeeding in a global marketplace. We examine the contract manufacturing outlook for China, against what pharmaceutical companies are looking for from their contract manufacturing organisation.
Are You Ready for Pharmaceutical Manufacturing in China?
Pharmaceuticals & Biotechnology Editor | 07/17/2012